We are live on ! Find out more
RVNC

Revance Therapeutics, Inc.
RVNC

Delisted

RVNC was delisted on the 5th of February, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of RVNC yet.

RVNC Hedge Fund Activity: Q2 2025 in Review

0 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Revance Therapeutics, Inc. (RVNC) for Q2 2025, worth a combined $0 — down 100% from $425K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of RVNC and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was DekaBank Deutsche Girozentrale, exiting entirely with an estimated $425K sold.

  • 0 institutional investors held Revance Therapeutics, Inc. (RVNC) as of Q2 2025, down from 1 in Q1 2025.
  • Funds reported $0 of Revance Therapeutics, Inc. stock for Q2 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Revance Therapeutics, Inc. positions in Q2 2025 and 1 closed out, a net change of -1 holder.
  • The largest Revance Therapeutics, Inc. seller in Q2 2025 was DekaBank Deutsche Girozentrale, an estimated $425K sold.

Based on aggregated 13F filings for Q2 2025.